Showing results (41-50 of 75) with videos related to
Sort By:
Pageof 8
Scientific Reports|February 23, 2017
Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approachLei Chang, Jie Ni, Julia Beretov, et al.Cancer Research|July 19, 2002
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinomaDavid O Bates, Tai-Gen Cui, Joanne M Doughty, et al.International Journal of Cancer|January 9, 2004
Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control studySteven E Oliver, David Gunnell, Jenny Donovan, et al.Journal of Clinical Epidemiology|August 19, 2003
Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study)Jenny L Donovan, Tim J Peters, Sian Noble, et al.Oncotarget|October 7, 2016
Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapyJingli Hao, Peter Graham, Lei Chang, et al.Urology|August 11, 2004
Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screeningSteven E Oliver, Jeff Holly, Tim J Peters, et al.Cancers|January 8, 2020
Rapid and Label-Free Isolation of Tumour Cells from the Urine of Patients with Localised Prostate Cancer Using Inertial MicrofluidicsAlexey S Rzhevskiy, Sajad Razavi Bazaz, Lin Ding, et al.Journal of Clinical Epidemiology|July 16, 2008
Development of a complex intervention improved randomization and informed consent in a randomized controlled trialJenny L Donovan, J Athene Lane, Tim J Peters, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancerSteven E Oliver, Barney Barrass, David J Gunnell, et al.European Urology Focus|October 23, 2019
Benefits and Harms of Electrical Neuromodulation for Chronic Pelvic Pain: A Systematic ReviewAngela M Cottrell, Marc P Schneider, Sanchia Goonewardene, et al.Pageof 8